What is CVE-2026-32917?

CVE-2026-32917 is a critical-severity vulnerability in Openclaw, classified under OS Command Injection. CVSS score: 9.8/10. Published 2026-03-31.

How severe is CVE-2026-32917?

Critical severity. CVSS v3 base score is 9.8 out of 10.

RCE in Openclaw

CVE-2026-32917

OpenClaw before 2026.3.13 contains a remote command injection vulnerability in the iMessage attachment staging flow that allows attackers to execute arbitrary commands on configured remote hosts. The vulnerability exists because unsanitized remote attachment paths containing shell metacharacters are passed directly to the SCP remote operand without validation, enabling command execution when remote attachment staging is enabled.

Vulnerability class: Command Injection (OS Command Injection)

EPSS: 0.020 (78.4th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 9.8 (Critical). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H.

Affected products

Openclaw — versions 0, 2026.3.13

Weakness classification (CWE)

CWE-78 — OS Command Injection

References

disclosure@vulncheck.com (vendor-advisory, Vendor Advisory, third-party-advisory)
disclosure@vulncheck.com (Patch, patch)
disclosure@vulncheck.com (Third Party Advisory, third-party-advisory)

Frequently asked questions

What is CVE-2026-32917?: CVE-2026-32917 is a critical-severity vulnerability in Openclaw, classified under OS Command Injection. CVSS score: 9.8/10. Published 2026-03-31.
How severe is CVE-2026-32917?: Critical severity. CVSS v3 base score is 9.8 out of 10.